MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about declaration of unmodified opinion

05 Jun 2021 Evaluate

With reference to the Audited Financial Results of the company for the fourth quarter (Q4) and financial year ended on March 31, 2021, which have been approved by the Board of Directors of the Company at their meeting held on, Friday, June 4, 2021, Ambalal Sarabhai Enterprises has declared that, Khandhar & Associates, Chartered Accountants, a Statutory Auditors of the Company have issued the Auditor's Report with an unmodified opinion on the Audited Financial Statements for financial year ended March 31, 2021. This declaration is made pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..